Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | +2.96% | -6.71% | +18.80% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Evolution of the average Target Price on Clearside Biomedical, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Clearside Biomedical, Inc.
HC Wainwright | |
Wedbush | |
JonesTrading Institutional Services | |
JMP Securities | |
Needham & Co. | |
Stifel Nicolaus | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- CLSD Stock
- Consensus Clearside Biomedical, Inc.